Home

Boston Scientific has received US FDA approval for its Lotus Edge transcatheter aortic valve implantation (TAVI) system. It is approved for patients with severe aortic stenosis who are considered at high risk for surgical valve replacement via open heart surgery. Prior to the approval, the only TAVI devices on the US market were Medtronic’s CoreValve and Edwards Lifesciences’ Sapien 3/Sapien XT.

According to a press release, the Lotus Edge valve system is the only FDA-approved aortic valve that gives physicians the option to reposition and completely recapture the valve once it has been fully deployed. The press release notes that the valve also features a braided valve frame and an adaptive seal that minimises paravalvular regurgitation or leaking by conforming to the patient’s native aortic valve.

Ian Meredith, executive vice president and global chief medical officer at Boston Scientific, comments: “We are thrilled to offer physicians in the USA and Europe the clinical benefits of the Lotus Edge valve system for the treatment of their high-risk patients with severe aortic stenosis. This system provides physicians a high level of control over the delivery and deployment of the device and offers surgical-like paravalvular leak results to help ensure the best patient outcomes.”

The FDA approval of the Lotus Edge valve system adds to the Boston Scientific suite of structural heart product solutions—including the Sentinel cerebral protection system and the Watchman left atrial appendage closure device—in the USA. In Europe, the Acurate neo TAVI is also available.

“Bringing the much-anticipated Lotus Edge valve system to market allows us to provide patients who are not good candidates for traditional surgery a safe and effective treatment alternative to restore proper function to their severely narrowed aortic valve. This technology is a fundamental component of our expanding portfolio and demonstrates our continuing commitment to category leadership within the fast-growing Structural Heart treatment landscape,” says Kevin Ballinger, executive vice president and global president, Interventional Cardiology, Boston Scientific.

The company commenced a controlled launch of the valve system in Europe in March and expects to begin a controlled launch in the USA in the coming weeks.

Chia sẽ qua facebook bài: Lotus Edge becomes third TAVI device on US market

Chia sẽ qua google bài: Lotus Edge becomes third TAVI device on US market

Chia sẽ qua twitter bài: Lotus Edge becomes third TAVI device on US market

Chia sẽ qua MySpace bài: Lotus Edge becomes third TAVI device on US market

Chia sẽ qua LinkedIn bài: Lotus Edge becomes third TAVI device on US market

Chia sẽ qua stumbleupon bài: Lotus Edge becomes third TAVI device on US market

Chia sẽ qua icio bài: Lotus Edge becomes third TAVI device on US market

Chia sẽ qua digg bài: Lotus Edge becomes third TAVI device on US market

Chia sẽ qua yahoo bài: Lotus Edge becomes third TAVI device on US market

Tin tức liên quan

Enrolment reaches midway point in trial of Early Bird bleed monitoring system

Eight-fold increased risk of heart attack seen in patients with subclinical obstructive coronary atherosclerosis

ACC 2023: REVIVED-BCIS-2 results challenge “long-held beliefs” on myocardial viability testing prior to PCI

Blood pressure successfully cut in RADIANCE II ultrasound renal denervation trial

New data examine mortality rates and cardiac damage in early-stage aortic stenosis patients

SUPPORT CONSULTANT

Make an Appointment

I am Nguyen Thanh Sang, born in 1990. Since the examination and treatment at the clinic Duc Tin, I am very grateful to the Doctor for explaining and sharing about my illness. During the treatment time in the clinic I was very caring staff of the clinic. Now my illness has improved in a good way. Expect more and more clinic to be able to save many patients.

I sincerely thank you !. Tel: 0938303275

Huynh Thi Muoi, born in 1940, was examined and treated at Duc Tin Clinic. I am very pleased about how to serve and care patients of the clinic. The doctor is committed to explaining and sharing with the patient.

Huynh Thi Muoi sincerely thank you! Phone number: 0972868746

As I said Duc Tin surgical clinin is where my family trust, hope to visit. Physicians caring, thoughtful, gentle to the patient. Nurses and staff clinic polite, cheerful and thoughtful. This clinic clean, sterile, so I would love to. Tel: +84949914060.

The doctor is very caring, attentive and very gentle nurse, courteous, affable with me. The clinic is clean, comfortable, polite. I enjoyed this faith. Every visit I was very relieved disease. Tel: 0839820792.

I was patient, had to clinics of Dr. Le Duc Tin. I see very conscientious doctor patient care, answer any questions and very dedicated staff from the receptionist to the children tested, nursing. Clinics very clean and spacious. I'm very satisfied. Tel: +841227880829.